We believe that our study makes a significant contribution to the literature because it clearly demonstrates that serum sPD‐1/sPD‐L1 may be involved in the immunosuppressive process in AP, and the serum sPD‐1 level may be an independent risk factor for predicting ICs in AP patients. Here, SPDL1 is linked to alkaline phosphatase measurement.